Polaryx Therapeutics raises $10 million to fund phase 2 trial
Go back to Polaryx Therapeutics raises $10 million to fund phase 2 trial| (NASDAQ: PLYX) | Delayed: 1.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.98 | 52 Week High | $ | |||
| Open | $1.98 | 52 Week Low | $ | |||
| Day High | $1.98 | P/E | N/A | |||
| Day Low | $1.98 | EPS | $ | |||
| Volume | 292 | |||||
